Haemonetics Corporation (HAE)

Haemonetics Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 27, 2025	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021
Net Income	175.44	167.68	117.56	115.4	43.38	79.47
Depreciation & Amortization	105.91	108.89	88.62	84.81	86.55	84.29
Other Amortization	6.7	6.7	8.6	8.5	11.8	0.56
Loss (Gain) From Sale of Assets	-1.66	-15.7	-1.01	-0.94	-9.6	-32.81
Asset Writedown & Restructuring Costs	9.3	2.39	10.42	0.61	10.75	21.97
Stock-Based Compensation	31.64	29.64	28.33	25.58	24.36	25.52
Other Operating Activities	-10.6	-15.91	3.94	13.6	20.21	-10.51
Change in Accounts Receivable	17.69	6.96	-24.19	-24.42	-34.97	44.12
Change in Inventory	38.54	-64.7	-60.06	30.75	24.31	-38.91
Change in Accounts Payable	-19.29	-19.21	44.58	39.82	7.64	-56.42
Change in Income Taxes	4.22	0.23	-0.98	1.69	2.87	-3.82
Change in Other Net Operating Assets	-19.04	-25.23	-34.05	-22.33	-15.02	-4.65
Operating Cash Flow	338.84	181.73	181.75	273.06	172.26	108.81
Operating Cash Flow Growth	162.16%	-0.01%	-33.44%	58.51%	58.32%	-31.23%
Capital Expenditures	-30.76	-39.28	-38.13	-191.33	-96.51	-37.04
Sale of Property, Plant & Equipment	3.3	23.25	1.81	1.61	2.02	1.82
Cash Acquisitions	-	-150.91	-243.85	-2.85	-2.5	-434.8
Divestitures	43.29	43.29	1.5	0.85	10.64	44.59
Investment in Securities	-39.67	-17.14	-15.55	-33.21	-	-
Other Investing Activities	-51.06	-21.11	-28.17	81.14	-	-
Investing Cash Flow	-74.89	-161.9	-322.39	-143.79	-86.35	-425.44
Long-Term Debt Issued	-	950	110	330	-	500
Total Debt Issued	-	950	110	330	-	500
Short-Term Debt Repaid	-	-	-	-	-	-60
Long-Term Debt Repaid	-	-502.69	-72.25	-339.63	-17.5	-69.28
Total Debt Repaid	-6.25	-502.69	-72.25	-339.63	-17.5	-129.28
Net Debt Issued (Repaid)	-6.25	447.31	37.75	-9.63	-17.5	370.73
Issuance of Common Stock	7.91	8.33	7.21	7.02	6.55	10.23
Repurchase of Common Stock	-229.96	-235.24	-5.89	-75	-	-
Other Financing Activities	-0.12	-111.58	-0.92	-22.76	-4.8	-13.5
Financing Cash Flow	-228.41	108.82	38.16	-100.36	-15.75	367.45
Foreign Exchange Rate Adjustments	6.99	-0.69	-3.19	-3.94	-2.98	4.18
Net Cash Flow	42.52	127.96	-105.67	24.97	67.19	54.99
Free Cash Flow	308.08	142.45	143.63	81.73	75.75	71.77
Free Cash Flow Growth	211.41%	-0.82%	75.73%	7.89%	5.56%	-34.44%
Free Cash Flow Margin	23.37%	10.47%	10.97%	6.99%	7.63%	8.24%
Free Cash Flow Per Share	6.40	2.81	2.79	1.59	1.48	1.40
Cash Interest Paid	16.53	16.53	20.9	13.59	6.19	7.82
Cash Income Tax Paid	49.29	49.29	52.71	17.97	24.3	12.49
Levered Free Cash Flow	335.05	183.89	149.37	50.09	88.9	133.37
Unlevered Free Cash Flow	365.49	206.33	161.56	58.21	89.12	138.68
Change in Working Capital	22.12	-101.96	-74.7	25.5	-15.18	-59.68

Updated Feb 5, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q